KHK 4577

Drug Profile

KHK 4577

Alternative Names: KHK4577

Latest Information Update: 27 Aug 2015

Price : $50

At a glance

  • Originator Kyowa Hakko Kirin
  • Class Anti-inflammatories; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atopic dermatitis

Most Recent Events

  • 24 Jul 2015 Discontinued - Phase-II for Atopic dermatitis in Japan (PO)
  • 30 Nov 2013 Phase-II clinical trials in Atopic dermatitis in Japan (PO)
  • 24 Jan 2013 Phase-I clinical trials in Inflammation in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top